Health insurance design involves structuring the financial relationship between the insurer and the insured to balance risk protection (the reason insurance exists), moral hazard control (reducing overconsumption of low-value care), and administrative feasibility. Key design elements include deductibles (patient pays the first N dollars), copayments (fixed dollar amount per service), coinsurance (patient pays a percentage of cost), and out-of-pocket maximums (caps total patient exposure). High-deductible health plans (HDHPs) reduce premiums and moral hazard but increase financial risk and may deter necessary care. Value-based insurance design (VBID) sets cost-sharing based on clinical value rather than cost — reducing barriers to high-value care while maintaining barriers to low-value care. Every design parameter trades off competing goals; the optimal design depends on the population's health, income, and the clinical value distribution of available services.
Insurance design is the art of balancing three competing objectives. Risk protection demands low patient exposure — the whole point of insurance is to prevent financial catastrophe from illness. Moral hazard control demands high patient exposure — when patients pay more, they consume less low-value care. Access demands that cost-sharing not deter necessary care — a deductible that prevents a diabetic patient from filling their insulin prescription defeats the purpose of health coverage. Every design element represents a position on these tradeoffs.
Deductibles require the patient to pay the first N dollars of annual costs before insurance activates. This eliminates insurance claims for minor, routine expenses (reducing administrative costs and moral hazard) but exposes patients to significant upfront costs. A $3,000 deductible means a patient must pay $3,000 out of pocket before any insurance benefit. For a healthy person with rare medical expenses, this is a good deal (low premiums). For a chronically ill person with monthly medication costs, the deductible is a major financial burden that may cause medication non-adherence.
Copayments (fixed dollar amounts per service) and coinsurance (percentage of cost) apply at the point of service. A $30 copay per physician visit creates a predictable cost that discourages trivial visits. 20% coinsurance on a $10,000 procedure ($2,000 patient share) creates a proportional cost that scales with the expense. Both maintain patient "skin in the game" after the deductible is met. The out-of-pocket maximum caps annual patient spending, providing catastrophic protection regardless of how much care is needed — once the cap is reached, insurance covers 100%.
Value-based insurance design represents the frontier of insurance design thinking. Rather than applying uniform cost-sharing across all services, VBID adjusts cost-sharing based on the clinical value of the service for the specific patient. Medications with strong evidence of benefit for a given condition have low or zero copays; services with weak evidence or better alternatives have high copays. This aligns financial incentives with clinical evidence — patients are steered toward value, not away from all care indiscriminately. The conceptual elegance is clear; the implementation challenge is that clinical value varies by patient, condition, and context, requiring sophisticated systems to implement effectively.